Key terms
About IPA
ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest IPA news
Apr 22
9:18am ET
ImmunoPrecise Antibodies announces expansion of LENS platform
Apr 12
9:07am ET
ImmunoPrecise Antibodies, InterSystems partner to leverage AI in life sciences
Mar 28
2:28pm ET
IPA and InterSystems Partner for AI-Driven Healthcare
Mar 28
7:37am ET
IPA and InterSystems Forge AI Healthcare Breakthrough
Mar 20
12:57pm ET
IPA Boosts AI Drug Discovery with Strategic Acquisition
Mar 20
7:37am ET
IPA Enhances Drug Discovery with Carterra LSA
Mar 20
7:15am ET
IPA acquires LSA instrument platform from Carterra, no terms
Mar 14
8:37am ET
IPA Continues Growth Streak, Slashes Cash Burn
Mar 07
7:37am ET
Immunoprecise Unveils AI Breakthrough in Life Sciences
No recent press releases are available for IPA
IPA Financials
Key terms
Ad Feedback
IPA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
IPA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
